Skip To Main Content
Marzia Defina on Muck Rack

Marzia Defina

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Marzia

Contact Marzia, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Favorable outcomes after early allogeneic stem cell transplantation in adult early T-cell precursor acute lymphoblastic leukemia treated with the pediatric-inspired GIMEMA LAL1913 program. A Campus ALL study

|
By Gianluca Cavallaro, Davide Lazzarotto, Chiara Pavoni, Francesca Valsecchi, Anna Grassi, Marco Cerrano, Monia Lunghi, Fabio Giglio, Silvia Imbergamo, Giuseppe Lanzarone, Antonino Mulè, Prassede Salutari, Patrizia Zappasodi, Massimiliano Bonifacio, Patrizia Chiusolo, Mario Delia, Carla Mazzone, Cristina Skert, Alessandro Rambaldi, Sabina Chiaretti, Robin Foà, Anna Candoni, Federico Lussana, Marzia Defina, Endri Mauro
| Nature Verified
To the Editor: Early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) is a rare, biologically distinct subtype of T-lineage ALL, defined by an immature immunophenotype and specific genomic features, which is recognized as a separate entity by the 2022 WHO classification. ETP-ALL accounts for a minority of T-ALL—5–17% of pediatric and ∼7% of adult cases- and has historically been considered a high-risk disease [1, 2].
Open in Who Shared Issue with article?
See all 1 articles